Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)
Clinical trial NCT05696548 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05696548
- Sponsor
- National Cancer Center Hospital East
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-02
- Primary completion
- 2025-09-10
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.